House Democrats change drug pricing bill in bid to address progressive concerns

House Democrats change drug pricing bill in bid to address progressive concerns
© Getty

House Democratic leaders are adjusting their signature bill to lower drug prices in an effort to address progressive concerns that a previous version of it was not strong enough.

The underlying bill will allow the Secretary of Health and Human Services to negotiate lower prices for up to 250 drugs per year, and the savings will apply to people in private insurance plans as well as Medicare. 

ADVERTISEMENT
The changes released Wednesday by the House Energy and Commerce Committee would increase the minimum number of drugs that must be negotiated from 25 to 35, and would require negotiation on some newly-launched drugs if their prices are more than the median U.S. household income. 

House progressives have been pushing to make the bill stronger, and the number of drugs and how to address launch prices of new drugs were both major objections that they had made, even as the move from 25 drugs to 35 drugs is not considered a major change. 

The measure is expected to pass the House later this month or early next month, though there are still concerns from some lawmakers. Senate Majority Leader Mitch McConnellAddison (Mitch) Mitchell McConnellOvernight Health Care: Fireworks on health care expected at Dem debate | Trump FDA pick dodges on vaping ban | Trump to host meeting on youth vaping Friday | AMA calls for immediate vaping ban GOP senator blocks vote on House-passed Violence Against Women Act On The Money: Senate scraps plan to force second shutdown vote | Trump tax breaks for low-income neighborhoods draw scrutiny | McConnell rips House Dems for holding up trade deal MORE (R-Ky.) has vowed to kill the bill in the Senate, calling it “socialist.”

Progressives had a range of reactions to the changes. 

A representative for the Congressional Progressive Caucus (CPC) had no immediate comment on the changes.

But Rep. Jan SchakowskyJanice (Jan) Danoff SchakowskyDemocrats request info on Google-Ascension partnership Drag queen attends first public Trump impeachment hearing Progressives ramp up fight against Facebook MORE (D-Ill.), a member of the progressive caucus and an ally of Speaker Nancy PelosiNancy PelosiKlobuchar shuts down idea a woman can't beat Trump: 'Pelosi does it every day' Budowsky: Trump destroying GOP in 2018, '19, '20 On The Money: Senate scraps plan to force second shutdown vote | Trump tax breaks for low-income neighborhoods draw scrutiny | McConnell rips House Dems for holding up trade deal MORE (D-Calif.), appeared to be won over by the changes, as she released a statement endorsing the bill on Tuesday night. 

Other progressives are still not satisfied, including Rep. Lloyd DoggettLloyd Alton DoggettWhite House talking new tax cuts with GOP On The Money: Lawmakers hammer Zuckerberg over Facebook controversies | GOP chair expects another funding stopgap | Senate rejects Dem measure on SALT deduction cap workarounds House committee advances measure taxing nicotine in vaping products MORE (D-Texas), who has been one of the most outspoken in pushing the bill in a more progressive direction. 

“Congressman Doggett is still vigorously pursuing substantial improvements to strengthen the bill,” a Doggett spokesperson said. 

Doggett is pushing for a range of changes, such as negotiation on more drugs and including protections against drug price spikes for people on private insurance plans and the uninsured. 

Alex Lawson, executive director of Social Security Works, a progressive group, said the changes move in the right direction. 

“We’re very proud, progressives are proud, of making H.R. 3 better,” he said. “It’s a significant down payment in the fight against pharma.”

Even before the changes, the Congressional Budget Office found the bill would save Medicare $345 billion over seven years. 

He said his group supports the bill but would also support additional improvements. 

On the other side of the spectrum, Rep. Stephanie MurphyStephanie MurphyTrump administration unveils new plan for notifying public on 2020 election interference Overnight Health Care: House Dems clash over Pelosi drug pricing bill | Senate blocks effort to roll back Trump ObamaCare moves | Number of uninsured children rises House Democrats clash over Pelosi's drug pricing bill MORE (D-Fla.), co-chairwoman of the centrist Blue Dog Coalition, declined to comment on whether she supports the bill. 

“That bill hasn’t even gotten a markup in my committee [yet],” she said.